Research Square · 2020 · 10 citations · 9 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyAntiviral AgentsAntiviral TherapyViral HepatitisViral InfectionsViral StructureVirus StructureAntiviral Structure-activity RelationshipsAntiviral TherapeuticsMultiple Sequence AlignmentMultiple Structural AlignmentNucleoside AnalogsSars-cov-2 Antiviral TherapySars-cov-2 InfectionStructure Superposition
Abstract As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the development of a vaccine might take several months or even years. The structural superposition of the hepatitis C virus polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for hepatitis C virus infections, with the SARS-CoV polymerase shows that the residues that bind to the drug are present in the latter. Moreover, a multiple alignment of several SARS-CoV-2, SARS and MERS-related coronaviruses polymerases shows that these residues are conserved in all these viruses, opening the possibility to use sofosbuvir against these highly infectious pathogens.
9
Tools for integrated sequence-structure analysis with UCSF Chimera
Elaine C. Meng, Eric F. Pettersen, Gregory S. Couch et al. · BMC Bioinformatics · 2006 · 763 citations · Full text